Back
CytoMed Therapeutics Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Buy
64
GDTC
CytoMed Therapeutics
Last Price:
$3.42
Seasonality Move:
-54.29%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Caught Trading Under Secret Name...
Find out more about the "hidden stock" here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDTC is experiencing selling pressure, which indicates risk of future bearish movement.
CytoMed Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3 | Buy |
| 20-day SMA: | 2.81 | Buy |
| 50-day SMA: | 2.56 | Buy |
| 200-day SMA: | 2.09 | Buy |
| 8-day EMA: | 3.12 | Buy |
| 20-day EMA: | 2.85 | Buy |
| 50-day EMA: | 2.56 | Buy |
| 200-day EMA: | 2.34 | Buy |
CytoMed Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 69.21 | Buy |
| Chaikin Money Flow: | -15464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.4 - 3.1) | Buy |
| Bollinger Bands (100): | (1.61 - 2.67) | Buy |
CytoMed Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Stock
Is CytoMed Therapeutics Stock a Buy?
-
CytoMed Therapeutics share price is 3.45 while GDTC 8-day simple moving average is 3.00, which is a Buy signal.
-
The stock price of GDTC is 3.45 while CytoMed Therapeutics 20-day SMA is 2.81, which makes it a Buy.
-
CytoMed Therapeutics 50-day simple moving average is 2.56 while GDTC share price is 3.45, making it a Buy technically.
-
GDTC stock price is 3.45 and CytoMed Therapeutics 200-day simple moving average is 2.09, creating a Buy signal.
GDTC Technical Analysis vs Fundamental Analysis
Buy
64
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy or a Sell?
-
CytoMed Therapeutics stock is rated a BuyThe current CytoMed Therapeutics [GDTC] share price is $3.45. The Score for GDTC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
CytoMed Therapeutics Stock Info
Market Cap:
39.8M
Price in USD:
3.45
Share Volume:
21.1K
CytoMed Therapeutics 52-Week Range
52-Week High:
4.86
52-Week Low:
1.20
Buy
64
CytoMed Therapeutics (GDTC)
is a Buy
CytoMed Therapeutics Share Price Forecast
-
What is the CytoMed Therapeutics stock price today?The CytoMed Therapeutics stock price is 3.45 USD today.
-
Will GDTC stock go up or go down?CytoMed Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is CytoMed Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics is not overvalued.
Is CytoMed Therapeutics Stock a Buy?
-
CytoMed Therapeutics share price is 3.45 while GDTC 8-day exponential moving average is 3.12, which is a Buy signal.
-
The stock price of GDTC is 3.45 while CytoMed Therapeutics 20-day EMA is 2.85, which makes it a Buy.
-
CytoMed Therapeutics 50-day exponential moving average is 2.56 while GDTC share price is 3.45, making it a Buy technically.
-
GDTC stock price is 3.45 and CytoMed Therapeutics 200-day simple moving average is 2.34, creating a Buy signal.
Fundamental Analysis of CytoMed Therapeutics
Is CytoMed Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of CytoMed Therapeutics
Should I short CytoMed Therapeutics stock?
-
GDTC Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting CytoMed Therapeutics is a Buy
-
CytoMed Therapeutics Relative Strength Index (RSI) is 69.21, which suggest CytoMed Therapeutics is overbought
-
The Bollinger Bands (25) for CytoMed Therapeutics is (2.4 - 3.1), which suggest CytoMed Therapeutics is a Buy
-
The Bollinger Bands (100) for CytoMed Therapeutics is (1.61 - 2.67), which suggest CytoMed Therapeutics is a Buy
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.